Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions

Pancreatic cancer (PDAC) is an aggressive and chemoresistant disease, representing the fourth cause of cancer related deaths in western countries. Majority of patients have unresectable, locally advanced or metastatic disease at time of diagnosis and the 5-year survival rate in these conditions is e...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Guido, Pancione, Massimo, Olivieri, Nunzio, Parcesepe, Pietro, Velocci, Marianna, Di Raimo, Tania, Coppola, Luigi, Toffoli, Giuseppe, D’Andrea, Mario Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583572/
https://www.ncbi.nlm.nih.gov/pubmed/28932079
http://dx.doi.org/10.3748/wjg.v23.i32.5875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583572/
https://www.ncbi.nlm.nih.gov/pubmed/28932079
http://dx.doi.org/10.3748/wjg.v23.i32.5875

Ejemplares similares